Echo Therapeutics, Inc. announced earnings results for the third quarter ended September 30, 2015. For the quarter, the company reported net loss of $1.8 million or $0.16 per share, compared to $2.7 million or $0.21 per share, for the same period in 2014. The $900,000 decrease in net loss was a result of decreases in research and development (R&D) and selling, general and administrative (S,G&A) expenses.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 154B | |
+31.66% | 112B | |
+1.37% | 64.16B | |
+19.45% | 54.88B | |
-2.27% | 46.69B | |
-9.28% | 36.8B | |
-0.10% | 35.26B |